The FDA shouldn't open the way for biosimilars for drugs approved before March 23, 2010, when Congress authorized the creation of a pathway for their approval, the Washington Legal Foundation said. The foundation weighed in to support a petition from Abbott Laboratories on the subject.
Legal foundation backs petition against pre-2010 biosimilars
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan